Bone, skin & immune
Ear, nose & throat
For more information, schedule a genetic counseling session firstname.lastname@example.org
Whole genome sequencing is ideal for finding new mutations and identifying atypical manifestations of a disease, especially for patients with a heterogeneous or atypical phenotype.
CentoGenome® offers you a state-of-the-art genomic analysis, with the most comprehensive analysis report, at a competitive price. Whole genome sequencing (WGS) is the superior way to diagnose complex or genetically undiagnosed diseases with the highest level of certainty.
The entire exome sequence provides information on all genes and identifies DNA changes by focusing on the most informative regions of the genome for a fast and cost-effective diagnostic solution.
The new Exom (WES) is stronger than ever!
The result: an analysis with the newly improved WES is more comprehensive than conventional WES testing and offers a faster diagnosis.
Biomarkers play an essential role in diagnosing, predicting and monitoring the therapy of several metabolic diseases, especially when patients have accessible treatment options.
Easy administration, continuous monitoring and responsible care.
Biomarker technology has increased use in disease diagnosis, drug development and treatment effectiveness.
Diagnostic accuracy by sequencing the entire genome at the price of a NGS panel!
Eliminates additional costs on step wise analysis like Del/Dup, follow up WES/WGS, or analysis of new genes associated with the phenotype when new information surfaces.
Comparative genomic hybridization is a molecular cytogenetic method for the analysis of variations in the number of copies (CNV). The CGH array allows the fast and efficient determination of the DNA sequences in the analyzed sample.